Spiking expression of mu-crystallin mRNA during treatment with methimazole in patients with graves' hyperthyroidism.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme

Volumn 41, Issue 7, 2009, Pages 548-553

  Suzuki, S ^a   Takei, M ^a   Nishio, S ^a   Inaba, H ^a   Sato, A ^a   Yamazaki, M ^a   Shinomiya, K ^a   Hashizume, K ^a  

^a SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; CRYSTALLIN; CRYSTALLIN MU; MESSENGER RNA; THIAMAZOLE; THYROID HORMONE;

ADULT; AGE; ARTICLE; BLOOD; CELL CULTURE; DRUG EFFECT; FEMALE; GENE EXPRESSION; GENETICS; GRAVES DISEASE; HUMAN; MALE; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; SEX DIFFERENCE; THYROID FUNCTION TEST;

ADULT; AGE FACTORS; ANTITHYROID AGENTS; CELLS, CULTURED; CRYSTALLINS; FEMALE; GENE EXPRESSION; GRAVES DISEASE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; METHIMAZOLE; MIDDLE AGED; RNA, MESSENGER; SEX FACTORS; THYROID FUNCTION TESTS; THYROID HORMONES;

EID: 70149118233     PISSN: None     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0029-1202865     Document Type: Article

References (0)